| Name | 4-({3-[7-(3,3-dimethyl-2-oxobutyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]propyl}amino)benzonitrile |
|---|---|
| Synonyms | Arrhythmias-Targeting Compound 1 |
| Description | Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, extracted from patent WO 2001028992 A2. |
|---|---|
| Related Catalog | |
| In Vivo | Arrhythmias-Targeting Compound 1 is used in the research of arrhythmias, in particular atrial and ventricular arrhythmias[1]. |
| References |
| Molecular Formula | C22H32N4O2 |
|---|---|
| Molecular Weight | 384.51500 |
| Exact Mass | 384.25300 |
| PSA | 68.60000 |
| LogP | 2.30928 |